Global Parkinson’s Disease Treatment Market is valued at USD 4.54 Billion in 2019 and expected to reach USD 6.97 Billion by 2026 with the CAGR of 6.33 % over the forecast period. Europe dominates the Global Parkinson’s disease Treatment market. The growth in the region is primarily due to presence of advanced healthcare infrastructure, sophisticated medical facilities, key players and growing prevalence of Parkinson’s disease. The region has more than 1 million people living with Parkinson’s today. Prevalence rate in the 60-69-year-old population is approximately 1.0% whereas in people over 80 its 2.7%. The figure is expected to double by 2030 with ageing population. Asia Pacific was fastest growing market with rising geriatric population in countries like China and Japan. The burden of disease is snowballing in China. It is projected that china will account about half of Parkinson’s disease population in the world by 2030.
